Calidi Biotherapeutics (CLDI) Short term Debt (2022 - 2024)

Calidi Biotherapeutics has reported Short term Debt for 3 years, with the latest figure at $223000.0 in Q4 2024.

• For the quarter ending Q4 2024, Short term Debt changed N/A year-over-year to $223000.0; the trailing twelve-month figure through Dec 2024 stood at $223000.0 (changed N/A YoY), and the FY2024 full-year result was $223000.0, changed N/A from the prior year.
• Short term Debt for Q4 2024 stood at $223000.0, up from $217000.0 in the prior quarter.
• The five-year high for Short term Debt was $1.0 million in Q4 2022, with the low at $134269.0 in Q1 2023.
• Average Short term Debt over 3 years is $407964.6, with a median of $220000.0 recorded in 2024.
• Peak annual rise in Short term Debt reached 52.68% in 2024, while the deepest fall reached 78.3% in 2024.
• Tracing CLDI's Short term Debt over 3 years: stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then sank by 77.7% to $223000.0 in 2024.
• The last three Short term Debt figures came in at $223000.0 (Q4 2024), $217000.0 (Q3 2024), and $211000.0 (Q2 2024), per Business Quant data.

Peer Comparison